Glycoprotein 100

What Glycoprotein 100 Means in Everyday Medical Language

Glycoprotein 100, often called gp100, is a protein made by cells that produce pigment, such as those in the skin and eyes. It is created from instructions in a gene called PMEL. This protein helps pigment cells develop and organize pigment inside them. In melanoma, a type of skin cancer, gp100 is often present and can be recognized by the immune system as a marker of cancer cells.

Why Glycoprotein 100 Can Matter in Cancer Care

Gp100 is important in cancer care because it is a target for certain cancer vaccines. These vaccines use small pieces of the gp100 protein to train the immune system to recognize and attack melanoma cells. This approach is part of immunotherapy research, which aims to help the body’s natural defenses fight cancer. While gp100 itself is not a treatment, it plays a role in developing new therapies for melanoma.

What Patients Might See or Hear About Glycoprotein 100

If you come across the term gp100 or Glycoprotein 100 in your medical records, test results, or treatment discussions, it may be related to cancer vaccines or research studies. It might also appear in reports about tumor markers or immune system targets. However, the presence of this term alone does not mean a specific diagnosis or treatment is planned. It is a scientific term that needs explanation from your care team to understand its relevance to your care.

Common Sources of Confusion and Related Terms

Gp100 can be confused with other glycoproteins, such as P-glycoprotein, which is a different protein involved in how cancer cells resist chemotherapy drugs. Glycoprotein 100 and P-glycoprotein are unrelated but have similar names. Also, gp100 may be called by other names like PMEL or premelanosome protein. Comparing the exact wording in your reports and asking your care team can help avoid confusion.

How to Read Glycoprotein 100 in Context

Seeing gp100 mentioned in a report or discussion should prompt questions about what it means for your specific case. It is not a diagnosis or a treatment by itself but a protein that may be part of research or vaccine development. Always ask your healthcare providers how gp100 relates to your diagnosis, treatment options, or clinical trials. Understanding the context helps you avoid misunderstanding or unnecessary worry.

Next Steps and Safety Information

This information is educational and does not replace medical advice. Glycoprotein 100 is a scientific term that may appear in cancer care discussions, especially related to melanoma. If you see this term in your medical records or hear it from your care team, the best next step is to ask them directly what it means for your care. They can explain how it fits into your diagnosis, treatment plan, or research opportunities. Always rely on your healthcare team to guide decisions about your care.